Investigating how POT1 mutations contribute to brain tumor development
Role of POT1 mutations in glioma initiation
This study is looking at how changes in a gene called POT1 might help start aggressive brain tumors called gliomas, and it’s for anyone interested in understanding more about these tumors and finding new ways to treat them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10694192 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of POT1 mutations in the initiation of gliomas, which are aggressive brain tumors. The study aims to explore how these mutations may lead to increased cell proliferation and the elongation of telomeres, potentially bypassing normal cellular aging processes. By using both mouse and human glial progenitor cells, researchers will investigate the mechanisms through which POT1 mutations influence glioma development. This could provide insights into the biological processes underlying these tumors and help identify new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a family history of gliomas or those who have been diagnosed with gliomas, particularly if they have mutations in the POT1 gene.
Not a fit: Patients with gliomas who do not have POT1 mutations or those with other types of brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with gliomas.
How similar studies have performed: Previous research has shown that mutations in POT1 are linked to other cancers, suggesting that this approach may yield valuable insights into glioma biology.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Jalali, Ali — Baylor College of Medicine
- Study coordinator: Jalali, Ali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.